By LabPulse.com staff writers
May 14, 2020 — Applied DNA Sciences has received emergency use authorization (EUA) from the U.S. Food and Drug Administration for a real-time reverse transcription polymerase chain reaction (RT-PCR) test for the novel coronavirus.
